153 related articles for article (PubMed ID: 32171552)
1. CXCL16 silencing alleviates hepatic ischemia reperfusion injury during liver transplantation by inhibiting p38 phosphorylation.
Zhang Y; Pan Q; Liu Y
Pathol Res Pract; 2020 May; 216(5):152913. PubMed ID: 32171552
[TBL] [Abstract][Full Text] [Related]
2. CXCL16/CXCR6 is involved in LPS-induced acute lung injury via P38 signalling.
Tu GW; Ju MJ; Zheng YJ; Hao GW; Ma GG; Hou JY; Zhang XP; Luo Z; Lu LM
J Cell Mol Med; 2019 Aug; 23(8):5380-5389. PubMed ID: 31199046
[TBL] [Abstract][Full Text] [Related]
3. EZH2 plays a crucial role in ischemia/reperfusion-induced acute kidney injury by regulating p38 signaling.
Liang H; Huang Q; Liao MJ; Xu F; Zhang T; He J; Zhang L; Liu HZ
Inflamm Res; 2019 Apr; 68(4):325-336. PubMed ID: 30820607
[TBL] [Abstract][Full Text] [Related]
4. TXNIP knockdown alleviates hepatocyte ischemia reperfusion injury through preventing p38/JNK pathway activation.
Zhang Y; Miao LS; Cai YM; He JX; Zhang ZN; Wu G; Zheng J
Biochem Biophys Res Commun; 2018 Jul; 502(3):409-414. PubMed ID: 29852169
[TBL] [Abstract][Full Text] [Related]
5. CXCL16/ROCK1 signaling pathway exacerbates acute kidney injury induced by ischemia-reperfusion.
Liang H; Liao M; Zhao W; Zheng X; Xu F; Wang H; Huang J
Biomed Pharmacother; 2018 Feb; 98():347-356. PubMed ID: 29275176
[TBL] [Abstract][Full Text] [Related]
6. Regulator of G-protein signaling 14 protects the liver from ischemia-reperfusion injury by suppressing TGF-β-activated kinase 1 activation.
Zhang JK; Ding MJ; Liu H; Shi JH; Wang ZH; Wen PH; Zhang Y; Yan B; Guo DF; Zhang XD; Tao RL; Yan ZP; Zhang Y; Liu Z; Guo WZ; Zhang SJ
Hepatology; 2022 Feb; 75(2):338-352. PubMed ID: 34455616
[TBL] [Abstract][Full Text] [Related]
7. CXCL16 protects against oxygen and glucose deprivation-induced injury in human microvascular endothelial cells-1: Potential role in ischemic stroke.
Wang M; Liu R
J Cell Physiol; 2019 Nov; 234(11):20149-20160. PubMed ID: 30945283
[TBL] [Abstract][Full Text] [Related]
8. Caspase recruitment domain 6 protects against hepatic ischemia/reperfusion injury by suppressing ASK1.
Qin JJ; Mao W; Wang X; Sun P; Cheng D; Tian S; Zhu XY; Yang L; Huang Z; Li H
J Hepatol; 2018 Nov; 69(5):1110-1122. PubMed ID: 29958938
[TBL] [Abstract][Full Text] [Related]
9. Investigate of AQP gene expression in the liver of mice after ischemia-reperfusion.
Karimi S; Khatami SR; Azarpira N; Galehdari H; Pakbaz S
Mol Biol Rep; 2018 Dec; 45(6):1769-1774. PubMed ID: 30143973
[TBL] [Abstract][Full Text] [Related]
10. CXCR6 deficiency ameliorates ischemia-reperfusion injury by reducing the recruitment and cytokine production of hepatic NKT cells in a mouse model of non-alcoholic fatty liver disease.
Zhu H; Zhang Q; Chen G
Int Immunopharmacol; 2019 Jul; 72():224-234. PubMed ID: 31002999
[TBL] [Abstract][Full Text] [Related]
11. CXCL16 deficiency attenuates acetaminophen-induced hepatotoxicity through decreasing hepatic oxidative stress and inflammation in mice.
Wang H; Shao Y; Zhang S; Xie A; Ye Y; Shi L; Jin L; Pan X; Lin Z; Li X; Yang S
Acta Biochim Biophys Sin (Shanghai); 2017 Jun; 49(6):541-549. PubMed ID: 28459937
[TBL] [Abstract][Full Text] [Related]
12. Cholecystokinin protects mouse liver against ischemia and reperfusion injury.
Zhang Y; Zhu J; Guo L; Zou Y; Wang F; Shao H; Li J; Deng X
Int Immunopharmacol; 2017 Jul; 48():180-186. PubMed ID: 28521244
[TBL] [Abstract][Full Text] [Related]
13. Oxidative and ER stress-dependent ASK1 activation in steatotic hepatocytes and Kupffer cells sensitizes mice fatty liver to ischemia/reperfusion injury.
Imarisio C; Alchera E; Bangalore Revanna C; Valente G; Follenzi A; Trisolini E; Boldorini R; Carini R
Free Radic Biol Med; 2017 Nov; 112():141-148. PubMed ID: 28739531
[TBL] [Abstract][Full Text] [Related]
14. Insulin-induced gene 2 protects against hepatic ischemia-reperfusion injury via metabolic remodeling.
Wu Y; Li C; Khan AA; Chen K; Su R; Xu S; Sun Y; Gao F; Wang K; Wang X; Lian Z; Wang S; Yu M; Hu X; Yang F; Zheng S; Qiu N; Liu Z; Xu X
J Transl Med; 2023 Oct; 21(1):739. PubMed ID: 37858181
[TBL] [Abstract][Full Text] [Related]
15. Functional role of endothelial CXCL16/CXCR6-platelet-leucocyte axis in angiotensin II-associated metabolic disorders.
Collado A; Marques P; Escudero P; Rius C; Domingo E; Martinez-Hervás S; Real JT; Ascaso JF; Piqueras L; Sanz MJ
Cardiovasc Res; 2018 Nov; 114(13):1764-1775. PubMed ID: 29800106
[TBL] [Abstract][Full Text] [Related]
16. Six-Transmembrane Epithelial Antigen of the Prostate 3 Deficiency in Hepatocytes Protects the Liver Against Ischemia-Reperfusion Injury by Suppressing Transforming Growth Factor-β-Activated Kinase 1.
Guo WZ; Fang HB; Cao SL; Chen SY; Li J; Shi JH; Tang HW; Zhang Y; Wen PH; Zhang JK; Wang ZH; Shi XY; Pang C; Yang H; Hu BW; Zhang SJ
Hepatology; 2020 Mar; 71(3):1037-1054. PubMed ID: 31393024
[TBL] [Abstract][Full Text] [Related]
17. The Chemokine Receptor CXCR6 Evokes Reverse Signaling via the Transmembrane Chemokine CXCL16.
Adamski V; Mentlein R; Lucius R; Synowitz M; Held-Feindt J; Hattermann K
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28698473
[TBL] [Abstract][Full Text] [Related]
18. Increase of SOX9 promotes hepatic ischemia/reperfusion (IR) injury by activating TGF-β1.
Fan XD; Zheng HB; Fan XS; Lu S
Biochem Biophys Res Commun; 2018 Sep; 503(1):215-221. PubMed ID: 29879429
[TBL] [Abstract][Full Text] [Related]
19. Activation of CXCL16/CXCR6 axis aggravates cardiac ischemia/reperfusion injury by recruiting the IL-17a-producing CD1d
Wang S; Ma L; Yang J; Dong Z; Wu J; Lu X; Wang J; Dai F; Tu G; Xu L; Zhao G; Zhang F; Zou Y; Ge J
Clin Transl Med; 2021 Feb; 11(2):e301. PubMed ID: 33634988
[No Abstract] [Full Text] [Related]
20. Helium preconditioning protects mouse liver against ischemia and reperfusion injury through the PI3K/Akt pathway.
Zhang R; Zhang L; Manaenko A; Ye Z; Liu W; Sun X
J Hepatol; 2014 Nov; 61(5):1048-55. PubMed ID: 24972044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
